Immediate Impact
16 standout
Citing Papers
Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
Works of A. Groffik being referenced
Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
2014
Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| A. Groffik | 507 | 390 | 325 | 9 | 601 | |
| Francis | 474 | 287 | 330 | 6 | 582 | |
| Nikhil Kamath | 370 | 233 | 243 | 10 | 523 | |
| Xiaoxia Zhu | 557 | 295 | 317 | 4 | 582 | |
| Sibylle Haemmerle | 374 | 84 | 128 | 22 | 661 | |
| Mary S. Bradley | 354 | 203 | 192 | 7 | 655 | |
| Uta Frieling | 227 | 164 | 292 | 12 | 550 | |
| Abdelkader Rahmaoui | 334 | 196 | 189 | 6 | 567 | |
| Gregory V. Marcotte | 181 | 86 | 63 | 9 | 602 | |
| Jun-ichi Kashiwakura | 209 | 71 | 47 | 8 | 538 | |
| Lucian Ionescu | 300 | 56 | 67 | 9 | 577 |
All Works
Loading papers...